Author:
Gobika Kugan MSc in Cancer, UCL Cancer Institute
Reviewed by:
Ayisham Saeed MSc-Chemistry (University of Punjab)
Nour Asaad MSc Applied Biomolecular Technology, BSc Biochemistry and Molecular Medicine, The University of Nottingham

Overview

Cancer occurring in the gastrointestinal (GI) tract affects vital organs, such as the stomach, colon, and anus, which play essential roles in the digestion, absorption and excretion of our food. More specifically, stomach (gastric) cancer has been ranked by Cancer Research UK as the eighteenth most commonly diagnosed cancer. While it may not rank among the most frequently diagnosed, its impact is severe, especially when looking at survival rates.1

Survival statistics of stomach cancer

In cancer statistics, the five-year survival rate is often used as a key measure, representing the percentage of patients who survive at least five years after their diagnosis or the start of treatment. For stomach cancer patients, the five-year survival rate ranged from 0% to 50%, depending on the stage and severity of the disease.2

This drastic contrast shows the importance of early detection and interventions in improving patient outcomes. To understand why stomach cancer can be detrimental, it is important to first review its vital role in maintaining overall health. 

What is the purpose of the stomach? 

The stomach is a complex organ that plays a central role in the digestive process while also performing important protective functions. Its key roles include the following:3

  1. Mechanical and chemical digestion: once partially digested food from the mouth enters the stomach, it undergoes further breakdown through a combination of muscular contractions and enzymatic activity. The stomach’s rhythmic contractions create a churning motion that mixes the food with gastric juice that is released by the stomach, including hydrochloric acid (HCl) and the enzyme pepsin. This process is essential for converting food into a semi-liquid form (chyme) that can pass smoothly into the small intestine for nutrient absorption
  2. Protein breakdown: HCl creates a highly acidic environment, which is necessary for the enzyme pepsin to work effectively. Pepsin is an enzyme that breaks down complex protein structures into smaller molecules, making them easier to absorb
  3. Defence against pathogens: the stomach’s acidity also serves a protective function by neutralising or killing harmful microorganisms (pathogens) that may enter the body through ingested food, acting as a first line of immune defence
  4. Mucosal protection: The harsh acidic environment created by the release of HCl can damage the stomach tissue. The stomach protects itself from damage by producing a thick mucus layer that coats the inner lining

Collectively, these functions highlight the complexity of the stomach, as it is required not only for digestion but also for the maintenance of GI health and protection of the body from external threats. Therefore, it is essential to protect and preserve the health of this vital organ. 

One key factor influencing stomach health is nutrition, which plays a significant role in both the initiation and progression of stomach cancer. By educating ourselves on how specific dietary choices impact cancer risk, we can take proactive steps toward better health. In this article, we will be exploring the following: 

Causes of stomach cancer: how can diet contribute to stomach cancer? 

Risk factors 

Cancer is a disease caused by genetic mutations (errors in the DNA) that disrupt the normal regulation of cell growth and division. These mutations can cause cells to multiply uncontrollably, leading to the formation of tumours. In the case of stomach cancer, several risk factors are known to contribute to its development. These include infection with Helicobacter pylori (H. pylori), dietary habits, genetics, and age. Understanding these risk factors is key to the prevention, early detection, and effective management of stomach cancer.2,4

Helicobacter pylori (H. pylori)

H. pylori is a type of bacteria that commonly infects the stomach and is recognised as the primary risk factor for gastric cancer. It can be transmitted directly from person to person or indirectly through ingesting food or water contaminated with an infected person’s saliva, vomit, or stool. One of the major challenges with H. pylori infection is that it is often asymptomatic, meaning many individuals do not experience any noticeable symptoms. As a result, the infection can go undetected for years, leading to chronic inflammation of the stomach lining. 

Reactive substances are released from activated immune cells attempting to eradicate the bacteria and from H. pylori itself as it attempts to infect host cells. This creates a toxic cellular environment that promotes DNA damage in the cells lining the stomach. Additionally, this bacterium can impair the cells’ natural DNA repair mechanisms. The combination of the ongoing DNA damage and compromised repair process promotes the accumulation of genetic mutations, which increases the risk of gastric cancer.5

Dietary habits and food choices

Several types of food and dietary habits have been associated with stomach cancer due to their potential to promote inflammation, damage the stomach lining, or contribute to carcinogenic processes. Examples include:

Being aware of these dietary risk factors can help guide healthier food choices, reducing the likelihood of stomach cancer development.

Genetics 

Genetic syndromes, such as juvenile polyposis syndrome (JPS) and Peutz-Jeghers syndrome (PJS), have been linked to an increased risk of developing stomach cancer. This is because they are characterised by the formation of polyps (non-cancerous abnormal growths) in the GI tract. While polyps are benign, their presence over time significantly elevates the risk of malignant transformation that can become cancerous over time. Because of this, people with these syndromes are monitored closely, and polyps are often removed to prevent complications.2,12

Ageing 

As we age, increased levels of inflammation and a decline in immune function commonly occur. This creates a cellular environment more susceptible to DNA damage and reduces the body’s ability to detect and eliminate abnormal cells. As a result, there is a heightened risk of accumulating genetic mutations, which can lead to uncontrolled cell division and, ultimately, the development of cancer.13

Digestive challenges in stomach cancer 

Stomach cancer can compromise the digestive process due to the effects of both the disease itself and the treatments used to manage it, such as surgery, chemotherapy and radiation. As the stomach plays a central role in breaking down food and regulating its passage to the intestines, any disruption to its structure or function can lead to digestive challenges. For example, when a small or large amount of the stomach is surgically removed (a procedure called a gastrectomy), patients may experience symptoms such as poor appetite, unintended weight loss, heartburn, abdominal pain, fatigue and anaemia (due to poor iron absorption).14,15 These changes often require dietary modifications to help manage symptoms and ensure adequate nutrition.

File:Depiction of a stomach cancer patient.png
By https://www.myupchar.com/en - https://www.myupchar.com/en/disease/stomach-cancer, CC BY-SA 4.0, Link

Recommended dietary strategies

For individuals with stomach cancer, adopting appropriate dietary strategies is essential to support overall health, manage symptoms, and improve treatment outcomes. Key strategies include:

Summary

Stomach cancer is influenced by a range of factors, including genetics, H. pylori infection, age, and particularly diet. Diets high in processed, salty, and smoked foods, as well as excessive alcohol consumption, are associated with increased cancer risk. On the other hand, adopting dietary strategies such as consuming small, frequent meals and prioritising a protein-rich diet can help manage symptoms and support recovery during treatment.

By learning more about the links between nutrition and stomach cancer, individuals can make informed choices that support prevention, improve outcomes, and enhance overall well-being. Whether through small dietary changes, increased awareness, or support during treatment, nutrition remains a powerful tool in managing this disease.

References

  1. Ogobuiro, Ifeanyichukwu, et al. ‘Physiology, Gastrointestinal’. StatPearls, StatPearls Publishing, 2025. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK537103/.
  2. Menon, Gopal, et al. ‘Gastric Cancer’. StatPearls, StatPearls Publishing, 2025. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK459142/.
  3. Hsu, Mark, et al. ‘Physiology, Stomach’. StatPearls, StatPearls Publishing, 2025. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK535425/.
  4. Health (US), National Institutes of, and Biological Sciences Curriculum Study. ‘Understanding Cancer’. NIH Curriculum Supplement Series [Internet], National Institutes of Health (US), 2007. www.ncbi.nlm.nih.gov, https://www.ncbi.nlm.nih.gov/books/NBK20362/.
  5. Salvatori, Silvia, et al. ‘Helicobacter Pylori and Gastric Cancer: Pathogenetic Mechanisms’. International Journal of Molecular Sciences, vol. 24, no. 3, Feb. 2023, p. 2895. PubMed Central, https://doi.org/10.3390/ijms24032895.
  6. Ma, Ke, et al. ‘Alcohol Consumption and Gastric Cancer Risk: A Meta-Analysis’. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, vol. 23, Jan. 2017, pp. 238–46. PubMed Central, https://doi.org/10.12659/MSM.899423.
  7. Wu, Xiaomin, et al. ‘Effect of Dietary Salt Intake on Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies’. Nutrients, vol. 14, no. 20, Oct. 2022, p. 4260. PubMed Central, https://doi.org/10.3390/nu14204260.
  8. Bojková, Bianka, et al. ‘Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence’. International Journal of Molecular Sciences, vol. 21, no. 11, June 2020, p. 4114. PubMed Central, https://doi.org/10.3390/ijms21114114.
  9. Moorthy, Bhagavatula, et al. ‘Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer’. Toxicological Sciences, vol. 145, no. 1, May 2015, pp. 5–15. PubMed Central, https://doi.org/10.1093/toxsci/kfv040.
  10. Kong, Pengfei, et al. ‘Vitamin Intake Reduce the Risk of Gastric Cancer: Meta-Analysis and Systematic Review of Randomized and Observational Studies’. PLoS ONE, vol. 9, no. 12, Dec. 2014, p. e116060. PubMed Central, https://doi.org/10.1371/journal.pone.0116060.
  11. Wu, Xiaomin, et al. ‘Dietary Patterns and Risk for Gastric Cancer: A Case-Control Study in Residents of the Huaihe River Basin, China’. Frontiers in Nutrition, vol. 10, Jan. 2023, p. 1118113. PubMed Central, https://doi.org/10.3389/fnut.2023.1118113.
  12. Meseeha, Marcelle, and Maximos Attia. ‘Colon Polyps’. StatPearls, StatPearls Publishing, 2025. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK430761/.
  13. White, Mary C., et al. ‘Age and Cancer Risk’. American Journal of Preventive Medicine, vol. 46, no. 3 0 1, Mar. 2014, pp. S7-15. PubMed Central, https://doi.org/10.1016/j.amepre.2013.10.029.
  14. Luu, Carrie, et al. ‘Impact of Gastric Cancer Resection on Body Mass Index’. The American Surgeon, vol. 80, no. 10, Oct. 2014, pp. 1022–25.
  15. Rosania, Rosa, et al. ‘Nutrition in Patients with Gastric Cancer: An Update’. Gastrointestinal Tumors, vol. 2, no. 4, May 2016, pp. 178–87. PubMed Central, https://doi.org/10.1159/000445188.
  16. Hui, Channing, and Gustavo J. Bauza. ‘Dumping Syndrome’. StatPearls, StatPearls Publishing, 2025. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK470542/.
  17. Orsso, Camila E., et al. ‘Effects of High-Protein Supplementation during Cancer Therapy: A Systematic Review and Meta-Analysis’. The American Journal of Clinical Nutrition, vol. 120, no. 6, Dec. 2024, pp. 1311–24. PubMed Central, https://doi.org/10.1016/j.ajcnut.2024.08.016.
  18. Ravasco, Paula. ‘Nutrition in Cancer Patients’. Journal of Clinical Medicine, vol. 8, no. 8, Aug. 2019, p. 1211. PubMed Central, https://doi.org/10.3390/jcm8081211.
  19. Lewis, Sharon R., et al. ‘Enteral versus Parenteral Nutrition and Enteral versus a Combination of Enteral and Parenteral Nutrition for Adults in the Intensive Care Unit’. The Cochrane Database of Systematic Reviews, vol. 2018, no. 6, June 2018, p. CD012276. PubMed Central, https://doi.org/10.1002/14651858.CD012276.pub2.
my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right